Comparison of cisplatin-induced nephrotoxicity when using conventional versus short hydration in gastric cancer-a retrospective study

被引:12
作者
Aoyama, Takeshi [1 ,3 ]
Tsunoda, Takashi [1 ]
Kato, Hiroki [1 ]
Hagino, Akane [1 ]
Furutani, Ryota [1 ]
Ito, Kazuyuki [1 ]
Yoshioka, Hidenori [1 ]
Nakamura, Masashi [1 ]
Hiraide, Makoto [1 ]
Kawakami, Kazuyoshi [1 ]
Kobayashi, Kazuo [1 ]
Suzuki, Kenichi [1 ]
Ichimura, Takashi [2 ]
Yamaguchi, Kensei [2 ]
Hama, Toshihiro [1 ]
机构
[1] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pharm, Tokyo, Japan
[2] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Chemotherapy, Tokyo, Japan
[3] 12 Kenichi Suzuki Hoshi Univ, Div Appl Pharmaceut Educ & Res, Shinagawa Ku, Ebara 2-4-41, Tokyo 1428501, Japan
关键词
Cisplatin; gastric cancer; hydration; magnesium supplementation; nephrotoxicity; short hydration; PATIENTS RECEIVING CISPLATIN; LUNG-CANCER; PHASE-III; CHEMOTHERAPY; MANNITOL; PHARMACOKINETICS; DIURESIS; REGIMEN; TRIAL;
D O I
10.1080/1120009X.2020.1713507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although a short hydration protocol for cisplatin has been recently developed for use in lung cancer, this has yet to be established for gastric cancer. This study reviewed medical records of patients with gastric cancer who received XPT(capecitabine/cisplatin/trastuzumab) therapy containing cisplatin. Patients received either the conventional or short hydration regimen. Nephrotoxicity was compared between these two regimens by monitoring the serum creatinine. Out of the 26 total patients, 19 received the conventional regimen while 7 received the short hydration regimen. There was a higher nephrotoxicity was observed in the group receiving the conventional regimen (42.1%, 8/19) as compared to the short hydration regimen (0%, 0/7). There was a statistically significant difference in nephrotoxicity between the regimens (P = 0.039). Study results suggest that short hydration may be a feasible regimen for XPT therapy in gastric cancer patients.
引用
收藏
页码:144 / 150
页数:7
相关论文
共 21 条
[1]  
ALSARRAF M, 1982, CANCER TREAT REP, V66, P31
[2]   Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II study [J].
Bodnar, Lubomir ;
Wcislo, Gabriel ;
Gasowska-Bodnar, Agnieszka ;
Synowiec, Agnieszka ;
Szarlej-Wcislo, Katarzyna ;
Szczylik, Cezary .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (17) :2608-2614
[3]  
CVITKOVIC E, 1977, CANCER-AM CANCER SOC, V39, P1357, DOI 10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO
[4]  
2-C
[5]   RENAL TUBULAR FUNCTION IN PATIENTS TREATED WITH HIGH-DOSE CISPLATIN [J].
DAUGAARD, G ;
ABILDGAARD, U ;
HOLSTEINRATHLOU, NH ;
BRUUNSHUUS, I ;
BUCHER, D ;
LEYSSAC, PP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (02) :164-172
[6]   A RANDOMIZED STUDY TO DETERMINE WHETHER ROUTINE INTRAVENOUS MAGNESIUM SUPPLEMENTS ARE NECESSARY IN PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY WITH CONTINUOUS-INFUSION 5-FLUOROURACIL [J].
EVANS, TRJ ;
HARPER, CL ;
BEVERIDGE, IG ;
WASTNAGE, R ;
MANSI, JL .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (02) :174-178
[7]  
HIGBY DJ, 1974, CANCER, V33, P1219, DOI 10.1002/1097-0142(197405)33:5<1219::AID-CNCR2820330505>3.0.CO
[8]  
2-U
[9]   Short Hydration in Chemotherapy Containing Cisplatin (≥ 75 mg/m2) for Patients with Lung Cancer: A Prospective Study [J].
Horinouchi, Hidehito ;
Kubota, Kaoru ;
Itani, Hidetoshi ;
Taniyama, Tomoko Katsui ;
Nakamichi, Shinji ;
Wakui, Hiroshi ;
Kanda, Shintaro ;
Nokihara, Hiroshi ;
Yamamoto, Noboru ;
Sekine, Ikuo ;
Tamura, Tomohide .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) :1105-1109
[10]   Reappraisal of Short-term Low-volume Hydration in Cisplatin-based Chemotherapy: Results of a Prospective Feasibility Study in Advanced Lung Cancer in the Okayama Lung Cancer Study Group Trial 1002 [J].
Hotta, Katsuyuki ;
Takigawa, Nagio ;
Hisamoto-Sato, Akiko ;
Ichihara, Eiki ;
Kudo, Kenichiro ;
Uchida, Koji ;
Yanase-Nakamura, Kayo ;
Tanaka, Hisaaki ;
Kato, Yuka ;
Tabata, Masahiro ;
Tanimoto, Mitsune ;
Kiura, Katsuyuki .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) :1115-1123